IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
Metastatic melanoma remains a refractory disease. Great progress in therapy of metastatic melanoma patients has been made in the recent five years. Targeted immunotherapy – a selective effect on lymphocytes signal molecules - became a principally new trend in the drug therapy of tumors. Ipilimumab i...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
Remedium Group LLC
2016-12-01
|
| Sarja: | Медицинский совет |
| Aiheet: | |
| Linkit: | https://www.med-sovet.pro/jour/article/view/1409 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|